Suchergebnisse - "Barlesi, F"

PubPharm (11)

1

Clinical utility of circulating tumor DNA sequencing with a large panel : a National Center for Precision Medicine (PRISM) study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Bayle, A. | Belcaid, L. | Aldea, M. | +31

CommentIn: Ann Oncol. 2023 Apr;34(4):333-335. - PMID 36804455

2

Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors : results from two phase 1 studies

enthalten in: Cancer immunology, immunotherapy : CII | 2022

von Moreno, V. | Calvo, E. | Middleton, M. | +11

3

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations : results from the IMMUNOTARGET registry

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Mazieres, J. | Drilon, A. | Lusque, A. | +35

CommentIn: Transl Cancer Res. 2019 Dec;8(Suppl 6):S628-S632. - PMID 35117146

4

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation : results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2017

von Leduc, C. | Merlio, J. | Besse, B. | +18

5

Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma

enthalten in: Revue des maladies respiratoires | 2016

von Fournier, C. | Greillier, L. | Fina, F. | +7

6

Management of patients with resistance to EGFR-TKI

enthalten in: Revue de pneumologie clinique | 2011

von Barlesi, F.

7

Biomarkers for today and tomorrow in thoracic oncology

enthalten in: Revue des maladies respiratoires | 2010

von Barlesi, F. | Greillier, L.

CommentOn: Rev Mal Respir. 2010 Apr;27(4):387-94. - PMID 20403548

8

Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung

enthalten in: British journal of cancer | 2005

von Barlési, F. | Pinot, D. | Legoffic, A. | +4

9

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy

enthalten in: British journal of cancer | 2005

von Barlési, F. | Tchouhadjian, C. | Doddoli, C. | +3

10

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer : results of a meta-analysis in 2063 patients

enthalten in: British journal of cancer | 2004

von Pujol, J. | Molinier, O. | Ebert, W. | +10